Bukwang Pharm (003000) — Capital Reinvestment Ratio
Bukwang Pharm (003000) has a Capital Reinvestment Ratio of 0.28x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩10.03 Billion) in capital expenditures (₩2.80 Billion). Check tangible net worth ratio of Bukwang Pharm to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bukwang Pharm Capital Reinvestment Ratio (2007–2024)
This chart tracks Bukwang Pharm's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Bukwang Pharm cash flow conversion.
Annual Capital Reinvestment Ratio for Bukwang Pharm (2007–2024)
Year-by-year Capital Reinvestment Ratio for Bukwang Pharm from 2007 to 2024. See 003000 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | ₩34.36 Billion | ₩2.61 Billion | ▼ -74.9% |
| 2022 | 0.30x | ₩16.46 Billion | ₩4.99 Billion | ▲ +924.3% |
| 2021 | 0.03x | ₩26.52 Billion | ₩785.05 Million | ▼ -98.9% |
| 2020 | 2.65x | ₩723.17 Million | ₩1.92 Billion | ▲ +387.4% |
| 2018 | 0.54x | ₩6.82 Billion | ₩3.71 Billion | ▲ +3.8% |
| 2017 | 0.52x | ₩8.56 Billion | ₩4.49 Billion | ▲ +17.8% |
| 2015 | 0.44x | ₩10.30 Billion | ₩4.58 Billion | ▲ +317.6% |
| 2014 | 0.11x | ₩27.86 Billion | ₩2.97 Billion | ▲ +3.8% |
| 2013 | 0.10x | ₩36.52 Billion | ₩3.74 Billion | ▼ -86.2% |
| 2007 | 0.74x | ₩27.87 Billion | ₩20.69 Billion | — |